{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "61934",
      "recalling_firm": "Ranbaxy Inc.",
      "address_1": "600 College Rd E Ste 2100",
      "address_2": "N/A",
      "postal_code": "08540-6636",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1405-2012",
      "product_description": "Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5% (from Coal Tar USP Solution, 7%), 7.5 oz bottle, Distributed by Ranbaxy, Jacksonville, FL 32257, NDC 10631-106-08",
      "product_quantity": "2544 bottles",
      "reason_for_recall": "Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.",
      "recall_initiation_date": "20120316",
      "center_classification_date": "20120703",
      "termination_date": "20130226",
      "report_date": "20120711",
      "code_info": "Lot #: RB81031, Exp 01/13"
    }
  ]
}